期刊文献+

小肠癌中内分泌型癌细胞的表达及其意义的研究 被引量:1

Study on the expression of neoplastic endocrine cells in the small intestine carcinomas and its significance
原文传递
导出
摘要 目的 对小肠癌中内分泌型癌细胞 (neoplasticendocrinecell,NEC)及其激素产物的表达情况进行研究 ,探讨小肠癌内分泌分化方向与其生物学行为之间的关系。方法 以嗜铬素A作为NEC的标志物 ,应用目前最先进的免疫组化方法 (SP法 )对 70例小肠癌 (十二指肠癌 4 8例 ,空肠癌 10例 ,回肠癌 12例 )进行嗜铬素A及 5种激素抗体的染色。结果  3 9例 ( 5 5 .7% )具有NEC ;5种激素的阳性率分别为血清素 3 8.6% ,生长抑素 3 2 .9% ,胰高糖素 15 .7% ,胃泌素 10 .0 % ,血管活性肠肽 14 .3 %。NEC的分布与小肠癌的发生部位无关 ,而与分化程度及转移有关 (P <0 .0 5 ) ,同时多激素表达与低分化小肠癌相关 (P <0 .0 5 )。结论 多数小肠癌具有不同种类和数量的NEC ,NEC阳性的小肠癌一般分化较差 ,易于发生转移 ;同时低分化小肠癌倾向于多种激素的表达。 Objective To elucidate the pathological and biological significances of endocrine differentiation present in small bowel cancer. Methods Chromogranin A (CGA) was used as the marker of neoplastic endocrine cell (NEC) in 70 small bowel cancers including 48 duodenal, 10 jejunal and 12 ileal cancers. The expression of CGA and five gut hormones in these tumors were immunohistochemically investigated with the update SP method. Results CGA positive endocrine cells were shown in 39(55.7%) tumors. Serotonin positive cells were found in 27(38.6%) cancers, somatostatin in 23 (32.9%), gastrin in 7(10.0%), glucagon in 11(15.7%), and VIP in 10(14.3%), respectively. Multiple immunoreactive cells were present most frequently in poorly differentiated cancers, not relevant to originative site. The NEC population was higher in poorly differentiated tumors than in those well differentiated. Conclusions NEC can be found in more than half of the small intestine carcinomas, and the tumors with NEC tend to be poorly differentiated and more vulnerabe to metastasis. There is a tendency of multiple hormone expression in small bowel cancers with more aggressive behavior.
出处 《中华消化杂志》 CAS CSCD 北大核心 2000年第2期92-94,共3页 Chinese Journal of Digestion
关键词 小肠癌 内分泌细胞 嗜铬素 激素 免疫组织化学 Intestinal neoplasms Endocrine cell Chromogranin Gut hormones Immunohistochemistry
  • 相关文献

参考文献1

二级参考文献14

共引文献27

同被引文献21

  • 1李国华,钱伟,侯晓华.胃腺癌组织中分泌血管活性肠肽的肿瘤细胞研究[J].中国实用内科杂志,2005,25(3):227-229. 被引量:3
  • 2陈潜,郑捷,盛宏森,陆国钧,范振符,倪莉,钟守先,陈元方.血管活性肠肽对人胰腺癌细胞生长的自分泌调节作用及其机制的研究[J].中华消化杂志,1994,14(3):128-132. 被引量:7
  • 3Said S I,Mutt V.Polypeptide with Broad-biological Activity:Isolation from Small Intestine[J].Science,1970,169:1217-1218.
  • 4Collado B,Carmena M J,Clemente C,et al.Vasoactive Intestinal Peptide Enhances Growth and Angiogenesis of Human Experimental Prostate Cancer in a Xenograft Model[J].Peptides,2007,28(9):1896-1901.
  • 5Zhang K,Aruva M R,Shanthly N,et al.Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase Activating Peptide (PACAP) Receptor Specific Peptide Analogues for PET Imaging of Breast Cancer:in Vitro/in Vivo Evaluation[J].Regul Pept,2007,144(1/3):91-100.
  • 6Hahm S H,Eiden L E.Five Discrete Cis-active Domains Direct Cell Type-specific Transcription of the Vasoactive Intestinal Peptide(VIP) Gene[J].J Biol Chem,1998,273(27):17086-17094.
  • 7Reubi J C.In Vitro Evaluation of VIP/PACAP Receptors in Healthy and Diseased Human Tissues.Clinical Implications[J].Ann NY Acad Sci,2000,921:1-25.
  • 8Kim S W,Beauchamp R D,Townsend C M,et al.Vasoactive Intestinal Polypeptide Inhibits C-myc Expression and Growth of Human Gastric Carcinoma Cells[J].Surgery,1991,110(2):270-275.
  • 9Watson K J,Shulkes A,Smallwood R A,et al.Watery Diarrhea-hypokalemia-achlorhydria Syndrome and Carcinoma of the Esophagus[J].Gastroenterology,1985,88(3):798-803.
  • 10Hejna M,Hamilton G,Brodowicz T,et al.Serum Levels of Vasoactive Intestinal Peptide (VIP) in Patients with Adenocarcinomas of the Gastrointestinal Tract[J].Anticancer Res,2001,21(2A):1183-1187.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部